| 发明名称 | Poxviral oncolytic vectors | ||
| 摘要 | A poxvirus comprising a defective F2L gene and compositions comprising such poxvirus are useful for therapeutic purposes, and more particularly for the treatment of cancer. | ||
| 申请公布号 | US9180150(B2) | 申请公布日期 | 2015.11.10 |
| 申请号 | US200812743412 | 申请日期 | 2008.11.17 |
| 申请人 | Transgene S.A. | 发明人 | Erbs Philippe;Foloppe Johann |
| 分类号 | A61K35/768;C07K14/005;C12N15/86;A61K38/45;A61K38/50 | 主分类号 | A61K35/768 |
| 代理机构 | Buchanan Ingersoll & Rooney PC | 代理人 | Buchanan Ingersoll & Rooney PC |
| 主权项 | 1. A method for treating a disease state, wherein a defective poxvirus whose genome is only defective of the F2L and JR2 genes is administered to a host organism or cell which is in need of such treatment. | ||
| 地址 | Illkirch FR | ||